
I-Renal cell carcinoma (I-RCC), uhlobo oluvame kakhulu lomdlavuza wezinso, ludinga indlela yokwelashwa yomuntu siqu esekelwe ezicini eziningana. Lo mhlahlandlela ophelele uhlola okuhlukahlukene ukwelashwa izinketho ze I-RCC, okuhlanganisa ukuhlinzwa, ukwelashwa okuhlosiwe, i-immunotherapy, nokwelashwa ngemisebe. Sizohlola intuthuko yakamuva kanye nokucatshangelwa kokukhetha indlela efanele yokutakula. Ukuqonda izinketho zakho kubalulekile ukuze wenze izinqumo ezinolwazi nethimba lakho lezempilo. Lolu lwazi ngelezinjongo zokufundisa kuphela futhi akufanele luthathe indawo yeseluleko sezokwelapha esichwepheshile.
I-RCC ihlanganisa ama-subtypes ambalwa, ngalinye linezici ezihlukile ezithonyayo ukwelashwa amasu. Isigaba somdlavuza, esinqunywa ubukhulu, indawo, nokusabalala kwawo, singesinye isici esibalulekile. Isiteji esinembile sibandakanya ukuhlolwa kwesithombe njengama-CT scan kanye ne-biopsy okungenzeka ibe khona. Ukutholwa kusenesikhathi kunomthelela omkhulu ukwelashwa impumelelo.
Ukukhetha kwe ukwelashwa okwe I-RCC kuncike ezicini eziningana, okuhlanganisa isigaba somdlavuza, impilo yesiguli iyonke, nokuba khona kwezinguquko ezithile zofuzo. Iminyaka yesiguli kanye nezifo ezigulayo nazo zidlala indima ebalulekile ekunqumeni inkambo engcono kakhulu yokwenza. Indlela yethimba lezinhlaka eziningi, ehlanganisa odokotela bomchamo, odokotela bezifo zomdlavuza, nabanye ongoti, imvamisa iyona ndlela ephumelela kakhulu yokuphatha. I-RCC.
Ukususwa ngokuhlinzwa kwezinso ezithintekile (ingxenye noma i-radical nephrectomy) kuvame ukuyinhloko ukwelashwa okwendawo I-RCC. Amasu ahlasela kancane, njengokuhlinzwa kwe-laparoscopic noma i-robotic, avame ukusetshenziswa ukunciphisa isikhathi sokutakula kanye nezinkinga. Ukuphumelela kokuhlinzwa kuncike ekupheleleni kokususwa kwesimila kanye nokungabikho kwe-metastasis.
Izindlela zokwelapha ezihlosiwe, njenge-sunitinib, i-sorafenib, i-zopanib, ne-axitinib, zisebenza ngokuvimbela amaprotheni athile aqhuba ukukhula kwamangqamuzana omdlavuza. Le mithi ivame ukusetshenziswa ezigabeni eziphambili ze I-RCC noma njenge-adjuvant therapy ngemva kokuhlinzwa. Imiphumela emibi iyehluka, futhi ukuqapha ngokucophelela kubalulekile. Funda kabanzi mayelana nemithi yokwelapha ehlosiwe evela ku-National Cancer Institute.
I-Immunotherapy ihlanganisa amasosha omzimba ukuze alwe namaseli omdlavuza. Ama-Checkpoint inhibitors, njenge-nivolumab ne-ipilimumab, aseguqukile I-RCC ukwelashwa, ikakhulukazi ezigabeni ezithuthukile. Le mithi ivimba amaprotheni avimbela amasosha omzimba ukuba ahlasele amangqamuzana omdlavuza. Imiphumela engemihle engaba khona ihlanganisa izehlakalo ezimbi ezihlobene nokuzivikela komzimba, ezidinga ukuphathwa ngokucophelela. Hlola izinketho ze-immunotherapy ezivela ku-American Cancer Society.
Ukwelapha ngemisebe kusebenzisa imishayo enamandla amakhulu ukubulala amangqamuzana omdlavuza. Ayisetshenziswa kakhulu njengesisekelo ukwelashwa okwe I-RCC kodwa ingase ibambe iqhaza ekulawuleni ubuhlungu, ukulawula ukuphindaphinda kwendawo, noma ukwelapha ama-metastases. I-Stereotactic body radiotherapy (SBRT) iwuhlobo olunembile lokwelapha ngemisebe enciphisa ukulimala kwezicubu ezinempilo ezizungezile.
Ukubamba iqhaza ezivivinyweni zomtholampilo kunikeza ukufinyelela onqenqemeni ukwelashwa izinketho futhi inikele ekuthuthukisweni ku I-RCC ucwaningo. Izivivinyo zemitholampilo zihlola imithi emisha, izindlela zokwelapha, kanye ukwelashwa amasu. Umhlinzeki wakho wokunakekelwa kwezempilo angakusiza ukuthi ubone ukuthi ukuhlolwa komtholampilo kusifanele yini isimo sakho esithile.
Okulungile ukwelashwa plan for I-RCC kuyisinqumo sokuhlanganyela phakathi kwesiguli nethimba laso lokunakekelwa kwezempilo. Ukuxhumana okuvulekile, ukuqonda okucacile kwe ukwelashwa izinketho, nokucatshangelwa ngokucophelela kwezinzuzo ezingaba khona kanye nemiphumela engemihle kubalulekile. Iziguli zikhuthazwa ukuba zifune imibono yesibili futhi zixoxisane kahle nodokotela bazo.
Okweziguli ezine-Advanced noma Metastatic I-RCC, ucwaningo oluqhubekayo luhlola ama-immunotherapies anoveli, izindlela zokwelapha ezihlosiwe, kanye nemithi ehlanganisiwe ukuze kuthuthukiswe imiphumela. I I-Shandong Baofa Cancer Research Institute uzinikele ekuthuthukiseni ukuqonda kanye ukwelashwa kwe I-RCC, okufaka isandla ezindleleni ezintsha ekunakekelweni komdlavuza.
| Uhlobo Lokwelapha | Izinzuzo | Ukubi |
|---|---|---|
| Ukuhlinzwa | Okungase kwelaphe i-RCC yendawo; izinketho ezincane ezihlaselayo ezitholakalayo. | Ingase ingalungeli zonke izigaba; amathuba okuba nezinkinga. |
| Ukwelapha Okuhlosiwe | Isebenza ku-RCC ethuthukisiwe; ingashwabanisa izimila futhi ithuthukise ukuphila. | Imiphumela engemihle ingabaluleka; akusebenzi kuzo zonke iziguli. |
| I-Immunotherapy | Iphumelela kakhulu kwezinye iziguli; amathuba okuxolelwa kwesikhathi eside. | Kungabangela imiphumela emibi ehlobene nokuzivikela komzimba; akusebenzi kuzo zonke iziguli. |
Umshwana wokuzihlangula: Lolu lwazi luhloselwe izinjongo zokufundisa kuphela futhi aluhlanganisi iseluleko sezokwelapha. Hlala uthintana nochwepheshe bezempilo abaqeqeshiwe ukuze uxilongwe futhi ulashwe noma yisiphi isimo sezempilo.
eceleni>